Literature DB >> 11591905

From beach to bedside: history of the development of sirolimus.

K L Napoli1, P J Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11591905     DOI： 10.1097/00007691-200110000-00012

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  34 in total

1.  Stent elution rate determines drug deposition and receptor-mediated effects.

Authors:  Abraham R Tzafriri; Adam Groothuis; G Sylvester Price; Elazer R Edelman
Journal:  J Control Release       Date:  2012-05-26       Impact factor: 9.776

2.  Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

Authors:  Darshika Chhabra; Anton I Skaro; Joseph R Leventhal; Pranav Dalal; Gaurav Shah; Edward Wang; Lorenzo Gallon
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

3.  mTOR Mediated Anti-Cancer Drug Discovery.

Authors:  Qingsong Liu; Carson Thoreen; Jinhua Wang; David Sabatini; Nathanael S Gray
Journal:  Drug Discov Today Ther Strateg       Date:  2009

4.  Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients.

Authors:  Ezra E W Cohen; Kehua Wu; Christine Hartford; Masha Kocherginsky; Kimberly Napoli Eaton; Yuanyuan Zha; Anitha Nallari; Michael L Maitland; Kammi Fox-Kay; Kristin Moshier; Larry House; Jacqueline Ramirez; Samir D Undevia; Gini F Fleming; Thomas F Gajewski; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2012-08-07       Impact factor: 12.531

5.  Subconjunctival sirolimus in the treatment of diabetic macular edema.

Authors:  Nupura Krishnadev; Farzin Forooghian; Catherine Cukras; Wai Wong; Leorey Saligan; Emily Y Chew; Robert Nussenblatt; Frederick Ferris; Catherine Meyerle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-13       Impact factor: 3.117

6.  A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients.

Authors:  Nicolas Picard; Aurélie Prémaud; Annick Rousseau; Yannick Le Meur; Pierre Marquet
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

7.  Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.

Authors:  Mayara Rodrigues Brandão De Paiva; Nayara Almeida Lage; Maria Carolina Andrade Guerra; Marcos Paulo Gomes Mol; Marcela Coelho Silva Ribeiro; Gustavo De Oliveira Fulgêncio; Dawidson A Gomes; Isabela Da Costa César; Sílvia Ligório Fialho; Armando Silva-Cunha
Journal:  Doc Ophthalmol       Date:  2018-11-19       Impact factor: 2.379

8.  Rapamycin in lipoproteins for enhanced delivery.

Authors:  Kyung-Hyun Cho
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

Review 9.  Mechanistic basis of immunotherapies for type 1 diabetes mellitus.

Authors:  Wenhao Chen; Aini Xie; Lawrence Chan
Journal:  Transl Res       Date:  2013-01-22       Impact factor: 7.012

Review 10.  Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.

Authors:  J Michael Tredger; Nigel W Brown; Anil Dhawan
Journal:  Drugs       Date:  2008       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.